Seres Therapeutics (MCRB) Net Margin (2016 - 2026)
Seres Therapeutics' Net Margin was 622.42% in Q2 2026, up 6184.71 percentage points from the prior quarter.
Powered by 
Analysis
Seres Therapeutics (MCRB) Net Margin (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Seres Therapeutics' Net Margin was -1192.94% through Jun 30, 2026; for FY2025, it was 721.93%.
- Net Margin shows a five-year change of +990.26 percentage points (FY2020 to FY2025).
- In earlier years, Net Margin was -3509.50% in FY2022 (-3464.25 pp) and -45.25% in FY2021 (+223.08 pp).
- Quarterly Net Margin has moved between -15436.77% (Q3 2023) and 2337.32% (Q3 2025) over five years.
- The best year-over-year quarter for Net Margin over five years was Q2 2023 (a gain of 5360.41 percentage points); the worst was Q3 2023 (a drop of 13694.56 percentage points).
- Per Business Quant data, MCRB's Net Margin in the three quarters before Q2 2026 was -5562.29% (Q1 2026), -3501.14% (Q4 2025) and 2337.32% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -1.65% |
| 10 | Seres Therapeutics | 22.42 Mn | -116.41 Mn | - | 622.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 622.42% |
| Mar 31, 2026 | -5,562.29% |
| Dec 31, 2025 | -3,501.14% |
| Sep 30, 2025 | 2,337.32% |
| Sep 30, 2023 | -15,436.77% |
| Jun 30, 2023 | 36.81% |
| Mar 31, 2023 | -13,634.87% |
| Dec 31, 2022 | -7,056.00% |
| Sep 30, 2022 | -1,742.22% |
| Jun 30, 2022 | -5,323.60% |
| Mar 31, 2022 | -3,792.63% |
| Dec 31, 2021 | -692.44% |
| Sep 30, 2021 | 53.83% |
| Jun 30, 2021 | -918.30% |
| Mar 31, 2021 | -620.23% |
| Dec 31, 2020 | -103.92% |
| Sep 30, 2020 | -2,136.91% |
| Jun 30, 2020 | -342.66% |
| Mar 31, 2020 | -242.78% |
| Dec 31, 2019 | -246.37% |
API Access
Seres Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=MCRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();